预测格雷夫斯甲亢患者开始抗甲状腺药物治疗前的复发风险。
Predicting the Risk of Recurrence Before the Start of Antithyroid Drug Therapy in Patients With Graves' Hyperthyroidism.
机构信息
Department of Endocrinology and Metabolism (X.G.V., W.M.W.), Department of Clinical Chemistry, Laboratory of Endocrinology (E.E.), Department of Clinical Epidemiology, Biostatistics, and Bioinformatics (A.H.Z.), and Department of Cardiology (J.G.P.T.), Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
出版信息
J Clin Endocrinol Metab. 2016 Apr;101(4):1381-9. doi: 10.1210/jc.2015-3644. Epub 2016 Feb 10.
PMID:26863422
Abstract
Genotyping increases the accuracy of a clinical score (based on pretreatment age, goiter size, FT4, TBII) for predicting recurrence of Graves' hyperthyroidism after a course of antithyroid drugs: a prospective study.
摘要
基因分型提高了预测抗甲状腺药物治疗后 Graves 甲亢复发的临床评分（基于治疗前年龄、甲状腺肿大小、FT4、TBII）的准确性：一项前瞻性研究。
Zotero 插件